Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 23, 2015 08:00 ET | Source: Marina Biotech, Inc.

Marina Biotech Expands Global Patent Protection of Clinical Stage Nucleic Acid Delivery Technologies

BOTHELL, WA--(Marketwired - Apr 23, 2015) - Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, announced today it has...
February 25, 2015 08:30 ET | Source: Marina Biotech, Inc.

Marina Biotech Provides 2014 Year-End Financials and Update

BOTHELL, WA--(Marketwired - Feb 25, 2015) - Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, today reported year-end...
December 18, 2014 08:00 ET | Source: Marina Biotech, Inc.

Marina Biotech and MiNA Therapeutics Announce License Agreement for the Development of saRNA-Based Therapeutics

BOTHELL, WA and SAN DIEGO, CA--(Marketwired - Dec 18, 2014) - Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, and...
December 09, 2014 08:00 ET | Source: Marina Biotech, Inc.

Marina Biotech Reports That Licensee ProNAi Therapeutics Presented Interim Phase 2 Data on Its BCL2-Targeting DNAi(R) Therapeutic at ASH 2014

BOTHELL, WA--(Marketwired - Dec 9, 2014) - Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, today reported that its...
November 20, 2014 08:30 ET | Source: Marina Biotech, Inc.

Marina Biotech Reports That Partner Mirna Therapeutics Presented Interim Phase 1 Data on Its First-in-Class microRNA-34 Mimic

BOTHELL, WA--(Marketwired - Nov 20, 2014) - Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, today reported that its...
November 18, 2014 08:00 ET | Source: Marina Biotech, Inc.

Rosetta Genomics and Marina Biotech Initiate First Clinical Project Under Strategic Alliance

PRINCETON, NJ and REHOVOT, ISRAEL and BOTHELL, WA--(Marketwired - Nov 18, 2014) - Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics and...
November 17, 2014 07:30 ET | Source: Marina Biotech, Inc.

Marina Biotech Announces Third Quarter 2014 Financial Results

BOTHELL, WA--(Marketwired - Nov 17, 2014) - Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, today reported...
September 16, 2014 07:30 ET | Source: Marina Biotech, Inc.

Marina Biotech Announces the Election of Donald A. Williams to Its Board of Directors

BOSTON, MA--(Marketwired - Sep 16, 2014) - Marina Biotech, Inc. (PINKSHEETS: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, announced today...
September 11, 2014 07:30 ET | Source: Marina Biotech, Inc.

Marina Biotech Announces the Continued Worldwide Expansion of Its Delivery Technology Intellectual Property Estate

BOSTON, MA--(Marketwired - Sep 11, 2014) - Marina Biotech, Inc. (PINKSHEETS: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, announced today...
September 03, 2014 07:30 ET | Source: Marina Biotech, Inc.

Marina Biotech to Present Rare Disease Clinical Strategy at Upcoming Investor Conferences

BOSTON, MA--(Marketwired - Sep 3, 2014) - Marina Biotech, Inc. (PINKSHEETS: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, today announced that...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right